Skip to content
Screener

Teladoc Health TDOC Q3 2025 earnings

Reported October 29, 2025 · After market close

Revenue$626.4MMiss by $8.9M
EPS-$0.21Beat by $0.05
Revenue estimate$635.3M
EPS estimate-$0.26

Next report

Oct 28, 2026 (in a month)
Revenue estimate$590.3M
EPS estimate-$0.23

Financials

Q3 2025

Income statement

See full
Revenue$626.4M-2.2%
Gross profit$439.3M-4.7%
Operating income-$52.0M-17.0%
Net income-$49.5M-48.8%
EPS (diluted)-$0.28-47.4%

Balance sheet

See full
Cash & equivalents$726.2M-41.6%
Total debt$48.0M-92.0%
Total equity$1.4B-7.7%
Total assets$2.9B-18.4%

Cash flow

See full
Operating cash flow$99.3M-9.9%
CapEx$2.3M+42.8%
Free cash flow$97.0M-10.7%

Valuation & ratios

Valuation

as of 09/30/25
See full
Market cap$1.37B-12.6%
Enterprise value$687.6M-25.0%
P/S0.5×-0.1×

Profitability

See full
Gross margin69.8%-1.0pp
Operating margin-10.9%-4.6pp
Net margin-8.8%-3.8pp
FCF margin11.1%-1.7pp

Returns & leverage

See full
Return on equity-15.4%-6.4pp
Debt / equity0×-0.4×
Current ratio2.7×+1.0×

Segments

By segment

See full
Integrated Care$389.5M+1.5%
BetterHelp$236.9M-7.8%

By product

See full
Access Fees$520.9M-6.2%
Other$105.5M+23.8%

FAQ

When did Teladoc Health report Q3 2025 earnings?
Teladoc Health (TDOC) reported Q3 2025 earnings on October 29, 2025 after market close.
What were Teladoc Health's Q3 2025 revenue and EPS?
Teladoc Health reported revenue of $626.4M and eps of $-0.21 for Q3 2025.
Did Teladoc Health beat estimates in Q3 2025?
Revenue missed the consensus estimate of $635.3M by $8.9M. EPS beat the consensus estimate of $-0.26 by $0.05.
How did Teladoc Health's Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 2.2% from $640.5M a year earlier and eps declined 10.5% from $-0.19.
Where can I find Teladoc Health's Q3 2025 SEC filings?
You can read the 8-K earnings release (0001477449-25-000117) and the 10-Q periodic report (0001477449-25-000120) directly on SEC EDGAR. The filing index links above go to sec.gov.